Explore Savara stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SVRA. Savara announces Phase 3 IMPALA-2 trial results for molgramostim in treating ...
Hosted on MSN1mon
SVRA stock touches 52-week low at $2.6 amid market challengesIn a turbulent market environment, Savara Inc. (NASDAQ:SVRA) stock has reached a 52-week low, dipping to $2.6. According to InvestingPro data, the company maintains strong liquidity with a current ...
Rhumbline Advisers lifted its stake in shares of Savara Inc (NASDAQ:SVRA – Free Report) by 6.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback